ID   OTUD3_HUMAN             Reviewed;         398 AA.
AC   Q5T2D3; O75047;
DT   30-AUG-2005, integrated into UniProtKB/Swiss-Prot.
DT   21-DEC-2004, sequence version 1.
DT   07-APR-2021, entry version 117.
DE   RecName: Full=OTU domain-containing protein 3;
DE            EC=3.4.19.12;
GN   Name=OTUD3; Synonyms=KIAA0459;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=9455484; DOI=10.1093/dnares/4.5.345;
RA   Seki N., Ohira M., Nagase T., Ishikawa K., Miyajima N., Nakajima D.,
RA   Nomura N., Ohara O.;
RT   "Characterization of cDNA clones in size-fractionated cDNA libraries from
RT   human brain.";
RL   DNA Res. 4:345-349(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [3]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-224, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [5]
RP   X-RAY CRYSTALLOGRAPHY (1.55 ANGSTROMS) OF 52-209, FUNCTION, CATALYTIC
RP   ACTIVITY, AND MUTAGENESIS OF 178-ARG--GLU-181.
RX   PubMed=23827681; DOI=10.1016/j.cell.2013.05.046;
RA   Mevissen T.E., Hospenthal M.K., Geurink P.P., Elliott P.R., Akutsu M.,
RA   Arnaudo N., Ekkebus R., Kulathu Y., Wauer T., El Oualid F., Freund S.M.,
RA   Ovaa H., Komander D.;
RT   "OTU deubiquitinases reveal mechanisms of linkage specificity and enable
RT   ubiquitin chain restriction analysis.";
RL   Cell 154:169-184(2013).
CC   -!- FUNCTION: Deubiquitinating enzyme that hydrolyzes 'Lys-6'- and 'Lys-
CC       11'-linked polyubiquitin. Also hydrolyzes heterotypic (mixed and
CC       branched) and homotypic chains. {ECO:0000269|PubMed:23827681}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Thiol-dependent hydrolysis of ester, thioester, amide, peptide
CC         and isopeptide bonds formed by the C-terminal Gly of ubiquitin (a 76-
CC         residue protein attached to proteins as an intracellular targeting
CC         signal).; EC=3.4.19.12; Evidence={ECO:0000269|PubMed:23827681};
CC   -!- INTERACTION:
CC       Q5T2D3; Q9BPX1: HSD17B14; NbExp=3; IntAct=EBI-16170539, EBI-742664;
CC       Q5T2D3; P60484-1: PTEN; NbExp=9; IntAct=EBI-16170539, EBI-15722967;
CC   -!- DOMAIN: The UBA-like domain has no influence on ubiquitin hydrolysis.
CC       {ECO:0000269|PubMed:23827681}.
CC   -!- DOMAIN: Specificity is given by the S1' ubiquitin-binding site within
CC       the OTU domain composed of the Cys-, His- and Variable-loops.
CC       {ECO:0000269|PubMed:23827681}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA32304.2; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB007928; BAA32304.2; ALT_INIT; mRNA.
DR   EMBL; AL391883; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS41279.1; -.
DR   RefSeq; NP_056022.1; NM_015207.1.
DR   PDB; 4BOU; X-ray; 1.55 A; A=52-209.
DR   PDBsum; 4BOU; -.
DR   SMR; Q5T2D3; -.
DR   BioGRID; 116856; 22.
DR   DIP; DIP-61702N; -.
DR   IntAct; Q5T2D3; 2.
DR   STRING; 9606.ENSP00000364261; -.
DR   MEROPS; C85.003; -.
DR   iPTMnet; Q5T2D3; -.
DR   PhosphoSitePlus; Q5T2D3; -.
DR   BioMuta; OTUD3; -.
DR   EPD; Q5T2D3; -.
DR   jPOST; Q5T2D3; -.
DR   MassIVE; Q5T2D3; -.
DR   MaxQB; Q5T2D3; -.
DR   PaxDb; Q5T2D3; -.
DR   PeptideAtlas; Q5T2D3; -.
DR   PRIDE; Q5T2D3; -.
DR   ProteomicsDB; 64331; -.
DR   Antibodypedia; 29739; 76 antibodies.
DR   Ensembl; ENST00000375120; ENSP00000364261; ENSG00000169914.
DR   GeneID; 23252; -.
DR   KEGG; hsa:23252; -.
DR   UCSC; uc001bcs.5; human.
DR   CTD; 23252; -.
DR   DisGeNET; 23252; -.
DR   GeneCards; OTUD3; -.
DR   HGNC; HGNC:29038; OTUD3.
DR   HPA; ENSG00000169914; Low tissue specificity.
DR   MIM; 611758; gene.
DR   neXtProt; NX_Q5T2D3; -.
DR   OpenTargets; ENSG00000169914; -.
DR   PharmGKB; PA142671215; -.
DR   VEuPathDB; HostDB:ENSG00000169914.5; -.
DR   eggNOG; ENOG502QUTD; Eukaryota.
DR   GeneTree; ENSGT00390000016392; -.
DR   HOGENOM; CLU_056188_0_0_1; -.
DR   InParanoid; Q5T2D3; -.
DR   OMA; WQIRGTE; -.
DR   OrthoDB; 1448656at2759; -.
DR   PhylomeDB; Q5T2D3; -.
DR   TreeFam; TF329594; -.
DR   PathwayCommons; Q5T2D3; -.
DR   Reactome; R-HSA-5689896; Ovarian tumor domain proteases.
DR   Reactome; R-HSA-8948751; Regulation of PTEN stability and activity.
DR   BioGRID-ORCS; 23252; 9 hits in 993 CRISPR screens.
DR   ChiTaRS; OTUD3; human.
DR   GenomeRNAi; 23252; -.
DR   Pharos; Q5T2D3; Tbio.
DR   PRO; PR:Q5T2D3; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; Q5T2D3; protein.
DR   Bgee; ENSG00000169914; Expressed in oocyte and 192 other tissues.
DR   Genevisible; Q5T2D3; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:MGI.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0008234; F:cysteine-type peptidase activity; IEA:UniProtKB-KW.
DR   GO; GO:0004843; F:thiol-dependent ubiquitin-specific protease activity; IDA:UniProtKB.
DR   GO; GO:0051898; P:negative regulation of protein kinase B signaling; IDA:MGI.
DR   GO; GO:0016579; P:protein deubiquitination; IBA:GO_Central.
DR   GO; GO:0035871; P:protein K11-linked deubiquitination; IDA:UniProtKB.
DR   GO; GO:1990167; P:protein K27-linked deubiquitination; IDA:MGI.
DR   GO; GO:0071108; P:protein K48-linked deubiquitination; IDA:MGI.
DR   GO; GO:0044313; P:protein K6-linked deubiquitination; IDA:UniProtKB.
DR   GO; GO:0050821; P:protein stabilization; IDA:MGI.
DR   InterPro; IPR003323; OTU_dom.
DR   InterPro; IPR038765; Papain-like_cys_pep_sf.
DR   Pfam; PF02338; OTU; 1.
DR   SUPFAM; SSF54001; SSF54001; 1.
DR   PROSITE; PS50802; OTU; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Hydrolase; Phosphoprotein; Protease; Reference proteome;
KW   Thiol protease; Ubl conjugation pathway.
FT   CHAIN           1..398
FT                   /note="OTU domain-containing protein 3"
FT                   /id="PRO_0000058103"
FT   DOMAIN          65..189
FT                   /note="OTU"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00139"
FT   DOMAIN          230..270
FT                   /note="UBA-like"
FT   REGION          70..76
FT                   /note="Cys-loop"
FT   REGION          127..137
FT                   /note="Variable-loop"
FT   REGION          177..182
FT                   /note="His-loop"
FT   ACT_SITE        73
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        76
FT                   /note="Nucleophile"
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        182
FT                   /evidence="ECO:0000250"
FT   MOD_RES         224
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   VARIANT         321
FT                   /note="N -> S (in dbSNP:rs2298110)"
FT                   /id="VAR_051258"
FT   VARIANT         333
FT                   /note="A -> T (in dbSNP:rs10916668)"
FT                   /id="VAR_051259"
FT   MUTAGEN         178..181
FT                   /note="RYGE->LSNG: Impaired activity."
FT                   /evidence="ECO:0000269|PubMed:23827681"
FT   HELIX           56..62
FT                   /evidence="ECO:0007744|PDB:4BOU"
FT   STRAND          65..68
FT                   /evidence="ECO:0007744|PDB:4BOU"
FT   HELIX           76..86
FT                   /evidence="ECO:0007744|PDB:4BOU"
FT   STRAND          87..89
FT                   /evidence="ECO:0007744|PDB:4BOU"
FT   HELIX           92..105
FT                   /evidence="ECO:0007744|PDB:4BOU"
FT   HELIX           107..110
FT                   /evidence="ECO:0007744|PDB:4BOU"
FT   HELIX           111..113
FT                   /evidence="ECO:0007744|PDB:4BOU"
FT   HELIX           120..128
FT                   /evidence="ECO:0007744|PDB:4BOU"
FT   HELIX           136..145
FT                   /evidence="ECO:0007744|PDB:4BOU"
FT   STRAND          149..153
FT                   /evidence="ECO:0007744|PDB:4BOU"
FT   STRAND          160..166
FT                   /evidence="ECO:0007744|PDB:4BOU"
FT   STRAND          172..178
FT                   /evidence="ECO:0007744|PDB:4BOU"
FT   TURN            179..181
FT                   /evidence="ECO:0007744|PDB:4BOU"
FT   STRAND          182..188
FT                   /evidence="ECO:0007744|PDB:4BOU"
SQ   SEQUENCE   398 AA;  45124 MW;  9C16E610CF1E3C5A CRC64;
     MSRKQAAKSR PGSGSRKAEA ERKRDERAAR RALAKERRNR PESGGGGGCE EEFVSFANQL
     QALGLKLREV PGDGNCLFRA LGDQLEGHSR NHLKHRQETV DYMIKQREDF EPFVEDDIPF
     EKHVASLAKP GTFAGNDAIV AFARNHQLNV VIHQLNAPLW QIRGTEKSSV RELHIAYRYG
     EHYDSVRRIN DNSEAPAHLQ TDFQMLHQDE SNKREKIKTK GMDSEDDLRD EVEDAVQKVC
     NATGCSDFNL IVQNLEAENY NIESAIIAVL RMNQGKRNNA EENLEPSGRV LKQCGPLWEE
     GGSGARIFGN QGLNEGRTEN NKAQASPSEE NKANKNQLAK VTNKQRREQQ WMEKKKRQEE
     RHRHKALESR GSHRDNNRSE AEANTQVTLV KTFAALNI
//
